Lang J M, Bigel P, Oberling F, Mayer S
Sem Hop. 1978;54(37-40):1155-8.
11 patients with Hodgkin's disease in remission, including 7 patients with an initial stage III-IV, off treatment for at least 6 months, were tested for blood T lymphocyte functions. All were completely re-evaluated at the end of treatment to assess complete remission. The number of peripheral blood lymphocytes was below 1,200/cu mm 5/11 patients. Absolute numbers of E-rosette-forming T lymphocytes were decreased in 8 patients, whereas active rosettes were normal in 4/6. A slightly increased percentage of EAC rosettes, a marker for B lymphocytes, was found in only 2 patients. In vitro lymphocyte reactivity to a sub-optimal dose of PHA was studied in 9 patients. A statistically significant defect of lymphocyte transformation was observed in the patient group T lymphocytes. A membrane change is suggested rather than a true depletion. The persistance of such abnormalities long after treatment may raise the question of a complementary immunostimulating treatment in these patients.
11例处于缓解期的霍奇金病患者,包括7例初始分期为III-IV期、停止治疗至少6个月的患者,接受了血液T淋巴细胞功能检测。所有患者在治疗结束时均进行了全面重新评估以评估完全缓解情况。11例患者中有5例外周血淋巴细胞数量低于1200/立方毫米。8例患者E玫瑰花结形成T淋巴细胞的绝对数量减少,而6例中有4例活性玫瑰花结正常。仅2例患者发现B淋巴细胞标志物EAC玫瑰花结百分比略有增加。对9例患者研究了体外淋巴细胞对亚最佳剂量PHA的反应性。在患者组T淋巴细胞中观察到淋巴细胞转化存在统计学上显著的缺陷。提示存在膜变化而非真正的耗竭。治疗后很长时间这些异常情况仍然存在,这可能会引发这些患者是否需要补充免疫刺激治疗的问题。